0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 281-300 of 588 Articles
Capitol Health Call | 
Mike Mitka, MSJ
JAMA. 2012;308(14):1421. doi:10.1001/jama.2012.12713.

Capitol Health Call | 
Mike Mitka, MSJ
JAMA. 2012;308(14):1421. doi:10.1001/jama.2012.13452.

Research Letters |  FREE
Emily Dodwell, MD, MPH; Brian Snyder, MD, PhD; James Wright, MD, MPH
JAMA. 2012;308(14):1429-1432. doi:10.1001/jama.2012.12929.

Viewpoint | 
Robert Steinbrook, MD; Joshua M. Sharfstein, MD
JAMA. 2012;308(14):1437-1438. doi:10.1001/jama.2012.12829.

Viewpoint | 
Jonathan M. Davis, MD; Edward M. Connor, MD, MBE; Alastair J. J. Wood, MB, ChB
JAMA. 2012;308(14):1435-1436. doi:10.1001/jama.2012.12883.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2012;308(13):1310. doi:10.1001/jama.2012.12679.

Medical News and Perspectives | 
Bridget M. Kuehn
JAMA. 2012;308(13):1307. doi:10.1001/jama.2012.13019.

Users' Guides to the Medical Literature | 
Edward J. Mills, PhD, MSc; John P. A. Ioannidis, MD, DSc; Kristian Thorlund, PhD, MSc; et al.
JAMA. 2012;308(12):1246-1253. doi:10.1001/2012.jama.11228.
Includes: Supplemental Content

Viewpoint | 
Elaine H. Morrato, DrPH, MPH; David B. Allison, PhD
JAMA. 2012;308(11):1097-1098. doi:10.1001/jama.2012.10007.

Capitol Health Call | 
Mike Mitka
JAMA. 2012;308(10):964. doi:10.1001/2012.jama.11530.

Research Letters |  FREE
Jeremy A. Greene, MD, PhD; Niteesh K. Choudhry, MD, PhD; Aaron S. Kesselheim, MD, JD, MPH; et al.
JAMA. 2012;308(10):973-975. doi:10.1001/2012.jama.10647.

Medical News and Perspectives | 
Tracy Hampton, PhD
JAMA. 2012;308(9):850-851. doi:10.1001/2012.jama.10451.

Viewpoint | 
Thomas J. Moore, AB; Curt D. Furberg, MD, PhD
JAMA. 2012;308(9):869-870. doi:10.1001/jama.2012.9658.

Viewpoint | 
Marc A. Rodwin, JD, PhD; John D. Abramson, MD, MS
JAMA. 2012;308(9):871-872. doi:10.1001/jama.2012.9661.

Medical News and Perspectives | 
Bridget M. Kuehn
JAMA. 2012;308(8):749-750. doi:10.1001/jama.2012.9289.

Capitol Health Call | 
Mike Mitka
JAMA. 2012;308(6):558. doi:10.1001/jama.2012.8914.

Capitol Health Call | 
Mike Mitka
JAMA. 2012;308(6):558. doi:10.1001/jama.2012.9558.

Medical News and Perspectives | 
Mike Mitka
JAMA. 2012;308(6):555. doi:10.1001/jama.2012.9535.

Editorial | 
James H. Stein, MD; Priscilla Y. Hsue, MD
JAMA. 2012;308(4):405-406. doi:10.1001/jama.2012.8488.

Viewpoint |  FREE
Anthony S. Fauci, MD; Gregory K. Folkers, MS, MPH
JAMA. 2012;308(4):343-344. doi:10.1001/jama.2012.8142.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Internal Medicine
Invited Commentary  | 
Finding Meaningful Patterns in Adverse Drug Event Reports
Joshua J. Gagne, PharmD, ScD
JAMA Internal Medicine
Invited Commentary  | 
Dopamine Receptor Agonist Drugs and Impulse Control Disorders
Howard D. Weiss, MD; Gregory M. Pontone, MD
JAMA Internal Medicine
Original Investigation  | 
Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs
Thomas J. Moore, AB; Joseph Glenmullen, MD; Donald R. Mattison, MD, MS
JAMA Dermatology
Case Report/Case Series  | 
Drug-Associated Dermatomyositis Following Ipilimumab Therapy:  A Novel Immune-Mediated Adverse Event Associated With Cytotoxic T-Lymphocyte Antigen 4 Blockade
Shirwa Sheik Ali, BSc; Allison L. Goddard, MD; Jason J. Luke, MD; et al.